{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:32:44Z","timestamp":1791873164899,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1038\/s41440-019-0327-2","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T06:02:52Z","timestamp":1569564172000},"page":"1971-1978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugs"],"prefix":"10.1038","volume":"42","author":[{"given":"Xiao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingping","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianbao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhui","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Fan Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. David","family":"Spence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"key":"327_CR1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/0002-9343(72)90054-X","volume":"52","author":"JH Laragh","year":"1972","unstructured":"Laragh JH, Baer L, Brunner HR, Buhler FR, Sealey JE, Vaughan ED Jr. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med. 1972;52:633\u201352.","journal-title":"Am J Med"},{"key":"327_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.7326\/0003-4819-82-1-27","volume":"82","author":"L Wallach","year":"1975","unstructured":"Wallach L, Nyarai I, Dawson KG. Stimulated renin: a screening test for hypertension. Ann Intern Med 1975;82:27\u201334.","journal-title":"Ann Intern Med"},{"key":"327_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/0002-9343(86)90819-3","volume":"80","author":"FB Muller","year":"1986","unstructured":"Muller FB, Sealey JE, Case DB, Atlas SA, Pickering TG, Pecker MS, et al. The captopril test for identifying renovascular disease in hypertensive patients. Am J Med. 1986;80:633\u201344.","journal-title":"Am J Med"},{"key":"327_CR4","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S0140-6736(86)91271-7","volume":"1","author":"DG Wong","year":"1986","unstructured":"Wong DG, Spence JD, Lamki L, McDonald JWD. Effect of non-steroidal anti-inflammatory drugs on control of hypertension by beta-blockers and diuretics. Lancet. 1986;1:997\u20131001.","journal-title":"Lancet"},{"key":"327_CR5","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S0895-7061(99)00154-5","volume":"12","author":"JD Spence","year":"1999","unstructured":"Spence JD. Physiologic tailoring of therapy for resistant hypertension: 20 years\u2019 experience with stimulated renin profiling. Am J Hypertens. 1999;12:1077\u201383.","journal-title":"Am J Hypertens"},{"key":"327_CR6","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1097\/HJH.0000000000002047","volume":"37","author":"M Nagasawa","year":"2019","unstructured":"Nagasawa M, Yamamoto K, Rakugi H, Takeda M, Akasaka H, Umakoshi H, et al. Influence of antihypertensive drugs in the subtype diagnosis of primary aldosteronism by adrenal venous sampling. J Hypertens. 2019;37:1493\u20139.","journal-title":"J Hypertens"},{"key":"327_CR7","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/ajh.2009.63","volume":"22","author":"BM Egan","year":"2009","unstructured":"Egan BM, Basile JN, Rehman SU, Davis PB, Grob CH III, Riehle JF, et al. Plasma renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens. 2009;22:792\u2013801.","journal-title":"Am J Hypertens"},{"key":"327_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/HYPERTENSIONAHA.118.11064","volume":"72","author":"JD Spence","year":"2018","unstructured":"Spence JD, Rayner BL. Hypertension in blacks: individualized therapy based on renin\/aldosterone phenotyping. Hypertension. 2018;72:263\u20139.","journal-title":"Hypertension"},{"key":"327_CR9","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/ajh\/hpx066","volume":"30","author":"A Akintunde","year":"2017","unstructured":"Akintunde A, Nondi J, Gogo K, Jones ESW, Rayner BL, Hackam DG, et al. Physiological phenotyping for personalized therapy of uncontrolled hypertension in Africa. Am J Hypertens. 2017;30:923\u201330.","journal-title":"Am J Hypertens"},{"key":"327_CR10","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1001\/jama.2015.2274","volume":"313","author":"Y Huo","year":"2015","unstructured":"Huo Y, Li J, Qin X, Huang Y, Wang X, Gottesman RF, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. J Am Med Assoc. 2015;313:1325\u201335.","journal-title":"J Am Med Assoc"},{"key":"327_CR11","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/clinchem\/18.6.528","volume":"18","author":"FH Katz","year":"1972","unstructured":"Katz FH, Smith JA. Radioimmunoassay of angiotensin I: comparison of two renin activity methods and use for other measurements of the renin system. Clin Chem. 1972;18:528\u201333.","journal-title":"Clin Chem"},{"issue":"6","key":"327_CR12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S2213-8587(18)30071-8","volume":"6","author":"Bryan Williams","year":"2018","unstructured":"Williams B, MacDonald TM, Morant SV, Webb DJ, Sever P, McInnes GT, et al. Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies. Lancet Diabetes Endocrinol. 2018;6:464\u201375.","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"327_CR13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ajh\/hpw167","volume":"30","author":"ES Jones","year":"2017","unstructured":"Jones ES, Spence JD, McIntyre AD, Nondi J, Gogo K, Akintunde A, et al. High frequency of variants of candidate genes in black africans with low renin-resistant hypertension. Am J Hypertens. 2017;30:478\u201383.","journal-title":"Am J Hypertens"},{"key":"327_CR14","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","volume":"369","author":"G Assie","year":"2013","unstructured":"Assie G, Libe R, Espiard S, Rizk-Rabin M, Guimier A, Luscap W, et al. ARMC5 mutations in macronodular adrenal hyperplasia with Cushing\u2019s syndrome. N Engl J Med. 2013;369:2105\u201314.","journal-title":"N Engl J Med"},{"key":"327_CR15","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1530\/EJE-15-0205","volume":"173","author":"R Correa","year":"2015","unstructured":"Correa R, Zilbermint M, Berthon A, Espiard S, Batsis M, Papadakis GZ, et al. The ARMC5 gene shows extensive genetic variance in primary macronodular adrenocortical hyperplasia. Eur J Endocrinol. 2015;173:435\u201340.","journal-title":"Eur J Endocrinol"},{"key":"327_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jash.2014.04.011","volume":"8","author":"CL Laffer","year":"2014","unstructured":"Laffer CL, Elijovich F, Eckert GJ, Tu W, Pratt JH, Brown NJ. Genetic variation in CYP4A11 and blood pressure response to mineralocorticoid receptor antagonism or ENaC inhibition: an exploratory pilot study in African Americans. J Am Soc Hypertens. 2014;8:475\u201380.","journal-title":"J Am Soc Hypertens"},{"key":"327_CR17","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S2213-8587(18)30071-8","volume":"6","author":"B Williams","year":"2018","unstructured":"Williams B, MacDonald TM, Morant SV, Webb DJ, Sever P, McInnes GT, et al. Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies. Lancet Diabetes Endocrinol. 2018;6:464\u201375.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"327_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/HJH.0000000000001171","volume":"35","author":"BL Rayner","year":"2017","unstructured":"Rayner BL, Spence JD. Hypertension in blacks: insights from Africa. J Hypertens. 2017;35:234\u20139.","journal-title":"J Hypertens"},{"key":"327_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1161\/01.HYP.0000022570.02119.75","volume":"40","author":"EH Baker","year":"2002","unstructured":"Baker EH, Duggal A, Dong Y, Ireson NJ, Wood M, Markandu ND, et al. Amiloride, a specific drug for hypertension in black people with T594M variant? Hypertension. 2002;40:13\u20137.","journal-title":"Hypertension"},{"key":"327_CR20","first-page":"1286","volume":"25","author":"ES Jones","year":"2012","unstructured":"Jones ES, Owen EP, Rayner BL. The association of the R563Q genotype of the ENaC with phenotypic variation in Southern Africa. Am J Hypertens. 2012;25:1286\u201391.","journal-title":"Am J Hypertens"},{"key":"327_CR21","first-page":"1","volume":"21","author":"ES Jones","year":"2010","unstructured":"Jones ES, Owen EP, Davidson JS, Van Der Merwe L, Rayner BL. The R563Q mutation of the epithelial sodium channel beta-subunit is associated with hypertension. Cardiovasc J Afr. 2010;21:1\u20134.","journal-title":"Cardiovasc J Afr"},{"key":"327_CR22","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1751-7176.2010.00359.x","volume":"12","author":"M Tapolyai","year":"2010","unstructured":"Tapolyai M, Uysal A, Dossabhoy NR, Zsom L, Szarvas T, Lengvarszky Z, et al. High prevalence of liddle syndrome phenotype among hypertensive US Veterans in Northwest Louisiana. J Clin Hypertens. 2010;12:856\u201360.","journal-title":"J Clin Hypertens"},{"key":"327_CR23","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/HJH.0000000000001556","volume":"36","author":"K Liu","year":"2018","unstructured":"Liu K, Qin F, Sun X, Zhang Y, Wang J, Wu Y, et al. Analysis of the genes involved in Mendelian forms of low-renin hypertension in Chinese early-onset hypertensive patients. J Hypertens. 2018;36:502\u20139.","journal-title":"J Hypertens"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0327-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0327-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41440-019-0327-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T03:52:02Z","timestamp":1721793122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-019-0327-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["327"],"URL":"https:\/\/doi.org\/10.1038\/s41440-019-0327-2","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,27]]},"assertion":[{"value":"27 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have completed the ICMJE uniform disclosure form and have declared the following: XH reports grants from the National Natural Science Foundation of China and Major Projects of the Science and Technology Department, Jiangxi, China; and XC reports a grant from the Major Projects of the Science and Technology Department, Jiangxi, China. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the ethics committee of the Second Affiliated Hospital of Nanchang University, China; the protocol number was *2017.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}